Direct accesses
Go to main menu
Go to main content
Menu
Search the site
Contact
Careers
You are viewing the website in English
en
fr
Search the site
Who
we are
Company
Leadership
Collaborations
Diseases
we target
Diseases we target
Leber Hereditary Optic Neuropathy (LHON)
Retinitis Pigmentosa (RP)
Geographic Atrophy in Dry-AMD
Our
technologies
Technologies we are applying
Gene Therapy
Mitochondrial Targeting Sequence (MTS)
Optogenetics
Clinical development Summary
Investors
Company Overview
Financial press releases
Investor Newsletters
Events & presentations
Stock information & Financial agenda
Governance
Documentation
Media
Documentation
Home
>
Investors & media
>
Documentation
Year
All
2024
2023
2022
2021
2020
2019
2018
2017
2016
Documentation type
All
General Assembly
Financial statements and reports
Regulated information
Corporate presentations
General meetings
07 November 2024
Regulated information
Monthly Information regarding the total number of shares
Open in new window
31 October 2024
Investor newsletter
Investor Newsletter – October 2024
Open in new window
07 October 2024
Regulated information
MONTHLY INFORMATION REGARDING THE TOTAL OF VOTING RIGHTS
Open in new window
07 October 2024
Regulated information
CONVERTIBLE BONDS ISSUED ON DECEMBER 28, 2022
Open in new window
30 September 2024
Corporate presentations
CORPORATE PRESENTATION – SEPTEMBER 2024
Open in new window
26 September 2024
Financial statements and reports
2024 HALF-YEAR FINANCIAL REPORT
Open in new window
23 September 2024
Regulated information
CONVERTIBLE BONDS ISSUED ON DECEMBER 28, 2022
Open in new window
17 July 2024
Regulated information
CONVERTIBLE BONDS ISSUED ON DECEMBER 28, 2022
Open in new window
12 July 2024
Regulated information
Monthly Information regarding the total number of voting rights
Open in new window
11 July 2024
Investor newsletter
Investor Newsletter – July 2024
Open in new window
1
2
3
4
5
6
…
21
View next 9 articles
Go back to the page of the page